
  
    
      
        Background_NNP
        Hypertension_NNP is_VBZ a_DT common_JJ medical_JJ problem_NN in_IN the_DT United_NNP
        States_NNPS ,_, occurring_VBG in_IN as_RB many_JJ as_IN 43_CD million_CD individuals_NNS [_NN 1_CD
        ]_NN ._. While_IN end-stage_JJ renal_JJ failure_NN represents_VBZ the_DT second_JJ
        most_RBS common_JJ cause_NN of_IN end-stage_JJ renal_JJ disease_NN [_NN 2_CD ]_NN ,_,
        perhaps_RB only_RB 1_CD in_IN 2_CD ,_, 500_CD hypertensive_JJ patients_NNS develops_VBZ
        clinically_RB important_JJ hypertensive_JJ nephrosclerosis_NNS ._. This_DT low_JJ
        frequency_NN of_IN end-organ_JJ renal_JJ damage_NN suggests_VBZ a_DT potential_JJ
        predisposition_NN to_TO this_DT complication_NN ._. The_DT inbred_JJ Dahl_NNP /_NN Rapp_NNP
        rat_NN is_VBZ a_DT genetic_JJ model_NN of_IN salt-sensitive_JJ hypertension_NN [_NN 3_CD 4_CD
        ]_NN ._. On_IN a_DT diet_NN containing_VBG 8_CD ._. 0_CD %_NN NaCl_NNP ,_, young_JJ Dahl_NNP /_NN Rapp_NNP
        salt-sensitive_JJ (_( S_NNP )_) rats_NNS rapidly_RB and_CC uniformly_RB manifest_JJ
        low-renin_JJ hypertension_NN and_CC die_VB from_IN hypertensive_JJ
        nephrosclerosis_NNS within_IN weeks_NNS of_IN institution_NN of_IN the_DT
        high-salt_JJ diet_NN [_NN 5_CD ]_NN ._. The_DT pathology_NN is_VBZ identical_JJ to_TO human_JJ
        hypertensive_JJ renal_JJ disease_NN and_CC consists_VBZ of_IN
        arteriolosclerosis_NNS ,_, glomerulosclerosis_NNS ,_, and_CC interstitial_NN
        scarring_VBG with_IN tubular_JJ cell_NN dropout_NN ._. While_IN other_JJ animal_NN
        models_NNS of_IN hypertension_NN can_MD be_VB employed_VBN to_TO study_VB the_DT
        pathogenesis_NNS of_IN hypertension_NN ,_, because_IN of_IN the_DT rapid_JJ and_CC
        reproducible_JJ development_NN of_IN renal_JJ failure_NN ,_, S_NNP rats_NNS provide_VBP a_DT
        unique_JJ means_VBZ to_TO investigate_VB the_DT pathogenesis_NNS of_IN
        hypertensive_JJ nephrosclerosis_NNS ._. In_IN this_DT respect_NN ,_, this_DT model_NN
        is_VBZ very_RB useful_JJ in_IN understanding_VBG hypertensive_JJ
        nephrosclerosis_NNS that_WDT occurs_VBZ in_IN human_JJ low-renin_JJ
        hypertension_NN ,_, especially_RB in_IN defined_VBN ,_, more_RBR homogeneous_JJ
        populations_NNS such_JJ as_IN the_DT black_JJ patients_NNS described_VBN by_IN Grim_NNP
        and_CC associates_NNS [_NN 6_CD ]_NN ._.
        Recent_JJ studies_NNS have_VBP shown_VBN that_IN apoptosis_NNS was_VBD accentuated_JJ
        in_IN kidneys_NNS of_IN S_NNP rats_NNS during_IN development_NN of_IN nephrosclerosis_NNS
        [_NN 7_CD ]_NN ._. These_DT studies_NNS demonstrated_VBN increased_VBN numbers_NNS of_IN
        TUNEL-positive_NNP cells_NNS ,_, increased_VBD cytoplasmic_JJ nucleosome_NN
        content_NN and_CC caspase-_NN 3_CD activation_NN in_IN kidneys_NNS of_IN hypertensive_JJ
        S_NNP rats_NNS ,_, compared_VBN to_TO normotensive_JJ Sprague-_NNP Dawley_NNP control_NN
        rats_NNS on_IN the_DT same_JJ high-salt_JJ diet_NN ._. An_DT increase_NN in_IN apoptosis_NNS
        rates_NNS in_IN glomeruli_NN and_CC tubules_NNS was_VBD observed_VBN ,_, confirming_VBG a_DT
        process_NN that_WDT involved_VBD several_JJ different_JJ cell_NN types_NNS in_IN the_DT
        kidney_NN ._. Apoptotic_NNP bodies_NNS were_VBD noted_VBN particularly_RB in_IN areas_NNS
        of_IN glomerular_NN sclerosis_NN and_CC in_IN dilated_JJ tubules_NNS ._. An_DT increase_NN
        in_IN the_DT number_NN of_IN PCNA-stained_NNP cells_NNS was_VBD also_RB demonstrated_VBN
        during_IN the_DT 21_CD -_: day_NN time_NN frame_NN ,_, but_CC because_IN renal_JJ function_NN
        deteriorated_VBD ,_, renal_JJ failure_NN correlated_JJ therefore_RB positively_RB
        with_IN apoptosis_NNS and_CC inversely_RB with_IN proliferation_NN rates_NNS ._.
        Thus_RB ,_, the_DT apoptotic_JJ process_NN appeared_VBD to_TO be_VB a_DT strong_JJ
        determinant_NN of_IN outcome_NN in_IN this_DT model_NN ._.
        The_DT Fas_NNP /_NN FasL_NNP system_NN transmits_NNS apoptotic_JJ signals_NNS from_IN the_DT
        surrounding_VBG environment_NN into_IN the_DT cell_NN ._. Fas_NNP contains_VBZ a_DT
        single_JJ transmembrane_NN domain_NN and_CC belongs_VBZ to_TO the_DT tumor_NN
        necrosis_NNS factor_NN (_( TNF_NNP )_) /_NN nerve_NN growth_NN factor_NN family_NN [_NN 8_CD ]_NN ._.
        FasL_NNP contains_VBZ a_DT single_JJ transmembrane_NN domain_NN and_CC is_VBZ also_RB a_DT
        member_NN of_IN the_DT same_JJ TNF_NNP family_NN [_NN 9_CD ]_NN ._. A_DT soluble_JJ form_NN of_IN
        FasL_NNP has_VBZ been_VBN described_VBN ,_, but_CC appears_VBZ to_TO be_VB less_RBR capable_JJ of_IN
        inducing_VBG apoptosis_NNS ,_, when_WRB compared_VBN with_IN the_DT bound_VBN form_NN [_NN 10_CD
        11_CD ]_NN ._. The_DT binding_JJ of_IN FasL_NNP with_IN Fas_NNP initiates_NNS receptor_NN
        oligomerization_NN ,_, which_WDT recruits_VBZ Fas-associated_NNP death_NN domain_NN
        (_( FADD_NNP )_) [_NN 12_CD ]_NN ._. FADD_NNP binds_NNS procaspase-_NN 8_CD and_CC permits_VBZ
        activation_NN of_IN caspase-_NN 8_CD through_IN self-cleavage_JJ [_NN 13_CD ]_NN ._.
        Caspase-_NNP 8_CD activates_NNS the_DT effector_NN caspases_NNS ,_, which_WDT commits_VBZ
        the_DT cell_NN to_TO the_DT orderly_JJ process_NN of_IN apoptosis_NNS [_NN 14_CD 15_CD ]_NN ._. In_IN
        addition_NN ,_, caspase-_NN 8_CD cleaves_NNS Bcl-_NNP 2_CD -_: interactive-death-agonist_JJ
        (_( Bid_NNP )_) [_NN 16_CD ]_NN ._. Truncated_NNP Bid_NNP localizes_NNS to_TO the_DT mitochondria_NN
        and_CC promotes_VBZ cytochrome_NN c_SYM release_NN ;_: this_DT process_NN also_RB serves_VBZ
        as_IN a_DT major_JJ apoptotic-signaling_JJ pathway_NN for_IN Fas_NNP [_NN 16_CD 17_CD 18_CD ]_NN
        ._. Depending_VBG upon_IN the_DT amount_NN of_IN caspase-_NN 8_CD that_WDT is_VBZ activated_VBN ,_,
        the_DT predominant_NN pathway_NN can_MD be_VB either_CC Bid_NNP cleavage_NN with_IN
        subsequent_JJ mitochondrial_NN release_NN of_IN cytochrome_NN c_SYM or_CC
        activation_NN of_IN the_DT effector_NN caspase_NN pathway_NN [_NN 18_CD ]_NN ._.
        Resident_NNP cells_NNS of_IN the_DT kidney_NN express_VBP both_DT Fas_NNP and_CC FasL_NNP and_CC
        Fas_NNP /_NN FasL_NNP signaling_VBG is_VBZ functional_JJ in_IN these_DT cells_NNS [_NN 19_CD 20_CD 21_CD
        22_CD 23_CD 24_CD ]_NN ._. A_DT recent_JJ review_NN by_IN Ortiz_NNP and_CC associates_NNS [_NN 25_CD ]_NN
        noted_VBD that_IN the_DT combined_VBN literature_NN demonstrating_VBG
        participation_NN of_IN Fas_NNP /_NN FasL_NNP pathway_NN in_IN renal_JJ injury_NN
        essentially_RB fulfilled_VBD Koch_NNP 's_POS postulates_NNS ._.
        In_IN kidneys_NNS of_IN S_NNP rats_NNS ,_, associated_VBN with_IN apoptosis_NNS was_VBD a_DT
        temporal_JJ increase_NN in_IN expression_NN of_IN Fas_NNP ,_, which_WDT was_VBD
        demonstrated_VBN using_VBG Western_JJ analysis_NN of_IN lysates_NNS of_IN kidney_NN
        cortex_NN [_NN 7_CD ]_NN ._. The_DT purpose_NN of_IN the_DT present_JJ study_NN was_VBD to_TO
        demonstrate_VB the_DT site_NN of_IN expression_NN and_CC potential_JJ functional_JJ
        significance_NN of_IN Fas_NNP and_CC FasL_NNP in_IN the_DT kidneys_NNS of_IN S_NNP rats_NNS
        during_IN development_NN of_IN hypertensive_JJ nephrosclerosis_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Animal_NNP preparation_NN
          Studies_NNS were_VBD conducted_VBN using_VBG 40_CD male_JJ Dahl_NNP /_NN Rapp_NNP
          salt-sensitive_JJ (_( SS_NNP /_NN Jr_NNP ,_, termed_VBD S_NNP )_) and_CC 40_CD male_JJ
          Sprague-_NNP Dawley_NNP (_( SD_NNP )_) rats_NNS ,_, initially_RB 28_CD days_NNS of_IN age_NN ,_,
          obtained_VBN from_IN Harlan_NNP Sprague_NNP Dawley_NNP ,_, Indianapolis_NNP ,_, IN_IN ._.
          The_DT rats_NNS were_VBD housed_VBN under_IN standard_JJ conditions_NNS and_CC given_VBN
          a_DT formulated_VBN diet_NN (_( AIN-_NNP 76_CD A_DT ,_, Dyets_NNP ,_, Inc_NNP ._. ,_, Bethlehem_NNP ,_, PA_NNP )_)
          that_WDT contained_VBD either_DT 0_CD ._. 3_CD %_NN or_CC 8_CD ._. 0_CD %_NN NaCl_NNP ._. These_DT diets_NNS were_VBD
          prepared_VBN specifically_RB to_TO be_VB identical_JJ in_IN protein_NN and_CC
          electrolyte_NN composition_NN and_CC differed_VBD only_RB in_IN NaCl_NNP and_CC
          sucrose_NN content_NN ._. Groups_NNS of_IN S_NNP and_CC SD_NNP rats_NNS on_IN 0_CD ._. 3_CD %_NN and_CC 8_CD ._. 0_CD %_NN
          NaCl_NNP were_VBD maintained_VBN contemporaneously_RB for_IN each_DT of_IN the_DT
          experiments_NNS performed_VBN ._. On_IN days_NNS 7_CD and_CC 21_CD of_IN study_NN ,_, rats_NNS
          from_IN all_PDT the_DT groups_NNS were_VBD anesthetized_JJ by_IN intraperitoneal_NN
          injection_NN of_IN sodium_NN pentobarbital_NN (_( Abbott_NNP Laboratories_NNPS ,_,
          North_NNP Chicago_NNP ,_, IL_NNP )_) ,_, 50_CD mg_NN /_NN kg_NN ._. Laparotomy_NNP was_VBD performed_VBN
          and_CC the_DT kidneys_NNS were_VBD perfused_JJ 
          in_IN situ_NN through_IN the_DT aorta_NN with_IN cold_JJ
          heparinized_JJ 0_CD ._. 9_CD %_NN NaCl_NNP solution_NN until_IN blanching_VBG occurred_VBN ,_,
          which_WDT generally_RB required_VBN infusion_NN of_IN 50_CD to_TO 60_CD ml_NN saline_NN
          over_IN 2_CD min_NN ._. Both_DT kidneys_NNS were_VBD harvested_VBN under_IN sterile_JJ
          conditions_NNS to_TO obtain_VB protein_NN for_IN Western_JJ analysis_NN and_CC for_IN
          light_JJ microscopy_NN and_CC histochemistry_NN after_IN fixation_NN in_IN 4_CD %_NN
          paraformaldehyde_NN in_IN PBS_NNP ._.
        
        
          In_IN situdetection_NN of_IN DNA_NNP fragmentation_NN using_VBG
          TUNEL_NNP
          
          In_IN situ_NN detection_NN of_IN DNA_NNP
          fragmentation_NN was_VBD performed_VBN by_IN incorporation_NN of_IN
          fluorescein-_NN 12_CD -_: dUTP_NN at_IN the_DT 3_CD '_POS -_: OH_NNP ends_NNS of_IN DNA_NNP using_VBG
          Terminal_NNP deoxynucleotidyl_NN Transferase_NNP (_( TUNEL_NNP assay_NN )_)
          (_( Apoptosis_NNP Detection_NNP System_NNP ,_, Fluorescein_NNP ,_, Promega_NNP ,_,
          Madison_NNP ,_, WI_NNP )_) ,_, as_IN performed_VBN previously_RB by_IN this_DT laboratory_NN
          [_NN 7_CD 26_CD ]_NN ._. Nuclei_NNP were_VBD counterstained_JJ using_VBG propidium_NN
          iodide_NN (_( Sigma_NNP Chemical_NNP Co_NNP ._. ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. For_IN
          fluorescein_NN ,_, the_DT excitation_NN and_CC barrier_NN filters_NNS were_VBD set_VBN
          at_IN 450_CD -_: 490_CD and_CC 515_CD -_: 560_CD nm_NN ,_, respectively_RB ._. Red_JJ fluorescence_NN
          of_IN propidium_NN iodide_NN was_VBD observed_VBN using_VBG excitation_NN and_CC
          barrier_NN filters_NNS of_IN 515_CD -_: 560_CD and_CC 580_CD nm_NN ,_, respectively_RB ._.
        
        
          Immunohistochemistry_NNP
          After_IN embedding_VBG in_IN paraffin_NN ,_, sections_NNS 5_CD μm_NN in_IN
          thickness_NN were_VBD immersed_VBN twice_RB into_IN xylene_NN for_IN 5_CD min_NN each_DT ,_,
          followed_VBN by_IN immersion_NN twice_RB for_IN 3_CD min_NN each_DT in_IN 100_CD %_NN
          ethanol_NN and_CC then_RB 95_CD %_NN ethanol_NN ._. Slides_NNS were_VBD rinsed_JJ for_IN 30_CD
          sec_NN using_VBG deionized_JJ water_NN and_CC then_RB immersed_VBN twice_RB in_IN
          deionized_JJ water_NN for_IN 5_CD min_NN ._. To_TO detect_VB Fas_NNP ,_, tissue_NN sections_NNS
          were_VBD initially_RB treated_VBN with_IN 1_CD %_NN SDS_NNP in_IN TBS_NNP (_( 100_CD mM_NN
          Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 4_CD ,_, 138_CD mM_NN NaCl_NNP and_CC 27_CD mM_NN KCl_NNP )_) for_IN 5_CD min_NN at_IN
          room_NN temperature_NN ,_, followed_VBN by_IN three_CD 5_CD -_: min_NN washes_NNS in_IN TBS_NNP
          alone_RB ._. Slides_NNS were_VBD covered_VBN in_IN 0_CD ._. 1_CD -_: 1_CD ._. 0_CD %_NN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 5_CD min_NN at_IN room_NN temperature_NN and_CC
          incubated_JJ in_IN goat_NN serum_NN for_IN 30_CD minutes_NNS at_IN room_NN
          temperature_NN ._. Slides_NNS were_VBD incubated_JJ for_IN 30_CD minutes_NNS at_IN room_NN
          temperature_NN in_IN PBS_NNP containing_VBG monoclonal_NN mouse_NN anti-human_JJ
          Fas_NNP /_NN CD_NNP 95_CD /_NN APO-_NNP 1_CD (_( Transduction_NNP Laboratories_NNPS ,_, Lexington_NNP ,_,
          Kentucky_NNP )_) ,_, 0_CD ._. 5_CD -_: 1_CD ._. 0_CD μg_NN /_NN ml_NN ,_, and_CC 10_CD %_NN goat_NN serum_NN ._. Slides_NNS were_VBD
          rinsed_JJ and_CC covered_VBN with_IN TBS_NNP containing_VBG 10_CD %_NN rat_NN serum_NN and_CC
          peroxidase-labeled_JJ polymer_NN conjugated_JJ to_TO goat_NN anti-mouse_JJ
          IgG_NNP (_( DAKO_NNP EnVision_NNP ™_NN +_NN System_NNP ,_, DAKO_NNP Corporation_NNP ,_,
          Carpinteria_NNP ,_, CA_NNP )_) for_IN 30_CD minutes_NNS at_IN room_NN temperature_NN and_CC
          color_NN was_VBD developed_VBN using_VBG 3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN (_( DAB_NNP )_)
          Chromogen_NNP solution_NN (_( DAKO_NNP )_) ._. Cells_NNP were_VBD counterstained_JJ
          using_VBG hematoxylin_NN and_CC the_DT slides_NNS were_VBD mounted_VBN in_IN standard_JJ
          fashion_NN ._. As_IN a_DT negative_JJ control_NN ,_, the_DT primary_JJ antibody_NN was_VBD
          omitted_VBN from_IN the_DT reaction_NN ._. As_IN an_DT additional_JJ control_NN ,_, the_DT
          anti-_NN Fas_NNP antibody_NN was_VBD pre-incubated_JJ with_IN recombinant_JJ
          soluble_JJ human_JJ Fas_NNP (_( PharMingen_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ,_, 0_CD ._. 5_CD μg_NN /_NN ml_NN ,_,
          for_IN 1_CD h_NN at_IN room_NN temperature_NN prior_RB to_TO use_VB as_IN the_DT primary_JJ
          antibody_NN to_TO stain_VB the_DT specimens_NNS ._. To_TO detect_VB FasL_NNP ,_,
          paraffin-embedded_JJ sections_NNS were_VBD initially_RB heated_JJ twice_RB at_IN
          95_CD °_NN C_NNP for_IN 5_CD min_NN in_IN 10_CD -_: mM_NN sodium_NN citrate_NN buffer_NN ,_, pH_NN 6_CD ._. 0_CD ._.
          Staining_NNP then_RB proceeded_VBD in_IN standard_JJ fashion_NN using_VBG goat_NN
          polyclonal_NN anti-_NN FasL_NNP antibody_NN (_( goat_NN polyclonal_NN antibody_NN
          IgG_NNP raised_VBD against_IN FasL_NNP (_( N-_NNP 20_CD )_) ,_, Santa_NNP Cruz_NNP Biotechnology_NNP ,_,
          Inc_NNP ._. ,_, Santa_NNP Cruz_NNP ,_, CA_NNP )_) ,_, 1_CD -_: 4_CD μg_NN /_NN ml_NN ,_, followed_VBN by_IN
          biotinylated_JJ donkey_NN anti-goat_JJ IgG_NNP ._. Color_NNP was_VBD developed_VBN
          using_VBG the_DT avidin-biotin_JJ detection_NN system_NN (_( ImmunoCruz_NNP
          Staining_NNP Systems_NNPS ,_, Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Inc_NNP ._. )_) ._.
          Immunoenzyme_NNP double_JJ staining_VBG of_IN kidney_NN tissue_NN was_VBD
          performed_VBN using_VBG DAKO_NNP EnVision_NNP Doublestain_NNP System_NNP (_( DAKO_NNP )_) ._.
          The_DT sections_NNS were_VBD initially_RB heated_JJ twice_RB at_IN 95_CD °_NN C_NNP for_IN 5_CD
          min_NN in_IN 10_CD -_: mM_NN sodium_NN citrate_NN buffer_NN ,_, pH_NN 6_CD ._. 0_CD ,_, and_CC then_RB
          incubated_JJ for_IN 30_CD min_NN with_IN the_DT mouse_NN anti-_NN Fas_NNP IgG_NNP
          (_( Transduction_NNP Laboratories_NNPS )_) ,_, 1_CD :_: 500_CD dilution_NN in_IN PBS_NNP
          containing_VBG 1_CD %_NN BSA_NNP ._. The_DT sections_NNS were_VBD incubated_JJ in_IN
          horseradish_NN peroxidase-conjugated_JJ goat_NN anti-rabbit_JJ and_CC
          goat_NN anti-mouse_JJ immunoglobulins_NNS for_IN 30_CD min_NN and_CC developed_VBN
          with_IN 3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN (_( DAB_NNP )_) Chromogen_NNP solution_NN
          (_( DAKO_NNP )_) ._. After_IN incubation_NN for_IN 10_CD min_NN in_IN the_DT Doublestain_NNP
          Block_NNP (_( DAKO_NNP )_) at_IN room_NN temperature_NN ,_, the_DT specimens_NNS were_VBD
          incubated_JJ for_IN 30_CD min_NN with_IN the_DT goat_NN anti-_NN FasL_NNP IgG_NNP (_( Santa_NNP
          Cruz_NNP Biotechnology_NNP ,_, Inc_NNP ._. )_) ,_, 1_CD :_: 50_CD dilution_NN in_IN PBS_NNP
          containing_VBG 1_CD %_NN BSA_NNP ._. The_DT samples_NNS were_VBD then_RB incubated_JJ with_IN
          alkaline_NN phosphatase-conjugated_JJ goat_NN anti-rabbit_JJ IgG_NNP and_CC
          goat_NN anti-mouse_JJ IgG_NNP for_IN 30_CD min_NN ._. The_DT slides_NNS were_VBD developed_VBN
          using_VBG alkaline-phosphatase_JJ substrate_NN to_TO produce_VB the_DT red_JJ
          color_NN ._. The_DT sections_NNS were_VBD then_RB counterstained_JJ using_VBG
          hematoxylin_NN before_IN study_NN ._.
          The_DT specimens_NNS were_VBD examined_VBN using_VBG a_DT light_JJ microscope_NN
          (_( Leica_NNP ,_, Germany_NNP )_) equipped_VBN with_IN a_DT digital_JJ camera_NN (_( Model_NNP
          C_NNP 5810_CD ,_, Hamamatsu_NNP Photonics_NNP K_NNP ._. K_NNP ._. )_) ._. Semi-quantification_NNP of_IN
          stained_JJ tubular_JJ epithelial_NN cells_NNS was_VBD determined_VBN at_IN ×_NN 20_CD
          magnification_NN by_IN projecting_VBG the_DT image_NN and_CC counting_VBG the_DT
          number_NN of_IN positive_JJ cells_NNS ;_: a_DT total_NN of_IN six_CD different_JJ fields_NNS
          were_VBD analyzed_VBN for_IN each_DT kidney_NN and_CC the_DT results_NNS were_VBD
          averaged_VBN to_TO produce_VB a_DT final_JJ count_NN for_IN each_DT kidney_NN ._.
          Quantification_NNP of_IN staining_VBG of_IN glomerular_NN compartment_NN was_VBD
          determined_VBN at_IN ×_NN 20_CD magnification_NN by_IN counting_VBG the_DT number_NN of_IN
          stained_JJ cells_NNS in_IN twenty-five_JJ glomeruli_NN ._.
        
        
          Immunoblot_NNP analysis_NN
          Samples_NNP of_IN renal_JJ cortex_NN from_IN S_NNP and_CC SD_NNP rats_NNS on_IN the_DT 0_CD ._. 3_CD %_NN
          and_CC 8_CD ._. 0_CD %_NN NaCl_NNP diets_NNS for_IN 7_CD and_CC 21_CD days_NNS were_VBD diced_JJ into_IN
          small_JJ pieces_NNS and_CC chilled_VBN in_IN 3_CD ml_NN of_IN ice_NN cold_JJ RIPA_NNP buffer_NN
          per_IN gram_NN of_IN tissue_NN ,_, then_RB homogenized_JJ (_( Omni-_NNP Mixer_NNP 17105_CD ;_:
          Omni_NNP ,_, Waterbury_NNP ,_, CT_NNP )_) in_IN standard_JJ fashion_NN ._. Reagents_NNP were_VBD
          from_IN Sigma_NNP Chemical_NNP Co_NNP ._. The_DT solutions_NNS were_VBD mixed_JJ gently_RB
          and_CC incubated_JJ on_IN ice_NN for_IN 30_CD min_NN ,_, then_RB homogenized_JJ by_IN
          passage_NN through_IN 21_CD -_: gauge_VB needle_NN ._. Thirty_NNP μl_NN of_IN
          phenylmethylsulfonyl_NN fluoride_NN (_( PMSF_NNP )_) ,_, 10_CD mg_NN /_NN ml_NN ,_, was_VBD added_VBN
          per_IN gram_NN of_IN tissue_NN and_CC incubated_JJ on_IN ice_NN for_IN 30_CD min_NN ._.
          Samples_NNP were_VBD centrifuged_JJ at_IN 15_CD ,_, 000_CD ×_NN 
          g_SYM for_IN 20_CD min_NN at_IN 4_CD °_NN C_NNP and_CC the_DT
          supernatant_NN was_VBD harvested_VBN ._. Total_JJ protein_NN of_IN each_DT sample_NN
          was_VBD determined_VBN using_VBG a_DT kit_NN (_( Micro_NNP BCA_NNP protein_NN assay_NN
          reagent_NN kit_NN ,_, Pierce_NNP ,_, Rockford_NNP ,_, IL_NNP ._. )_) ._. For_IN each_DT experiment_NN
          that_WDT examined_VBD a_DT protein_NN of_IN interest_NN ,_, all_DT samples_NNS were_VBD
          processed_VBN simultaneously_RB ._. Samples_NNP containing_VBG 60_CD μg_NN of_IN
          total_JJ protein_NN were_VBD mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN 2_CD x_SYM
          SDS-Laemmli_NNP sample_NN buffer_NN (_( 100_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 6_CD ._. 8_CD ,_, 20_CD %_NN
          glycerol_NN ,_, 200_CD mM_NN dithiothreitol_NN ,_, 4_CD %_NN SDS_NNP ,_, and_CC 0_CD ._. 2_CD %_NN
          bromphenol_NN blue_JJ )_) and_CC boiled_VBD for_IN 5_CD min_NN ,_, then_RB resolved_VBN
          using_VBG either_CC 12_CD %_NN SDS-polyacrylamide_NNP gel_NN electrophoresis_NNS ._.
          Proteins_NNPS were_VBD transferred_VBN on_IN to_TO nitrocellulose_NN membrane_NN
          using_VBG an_DT electroblotting_VBG apparatus_NN (_( Bio-_NNP Rad_NNP ,_, Richmond_NNP ,_,
          CA_NNP )_) ._. Following_VBG incubation_NN in_IN blocking_VBG buffer_NN (_( 10_CD mM_NN
          Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, containing_VBG 10_CD %_NN non-fat_JJ dry_JJ milk_NN ,_, 100_CD mM_NN
          NaCl_NNP ,_, and_CC 0_CD ._. 1_CD %_NN Tween_NNP 20_CD )_) ,_, the_DT membranes_NNS were_VBD probed_JJ with_IN
          an_DT affinity-purified_JJ rabbit_NN polyclonal_NN IgG_NNP directed_VBD
          against_IN caspase-_NN 8_CD (_( Caspase-_NNP 8_CD p_NN 20_CD ,_, Santa_NNP Cruz_NNP
          Biotechnology_NNP ,_, Inc_NNP ._. ,_, Santa_NNP Cruz_NNP ,_, CA_NNP )_) ,_, 1_CD :_: 200_CD dilution_NN in_IN
          blocking_VBG buffer_NN ,_, overnight_JJ at_IN 4_CD °_NN C_NNP ._. The_DT membranes_NNS were_VBD
          then_RB washed_VBN five_CD times_NNS with_IN TBS-Tween_NNP and_CC were_VBD incubated_JJ
          with_IN horseradish_NN peroxidase-conjugated_JJ donkey_NN anti-rabbit_JJ
          IgG_NNP (_( Bio-_NNP Rad_NNP ,_, Hercules_NNP ,_, CA_NNP )_) ,_, 1_CD :_: 5_CD ,_, 000_CD dilution_NN ._. After_IN
          three_CD additional_JJ washes_NNS using_VBG TBS-Tween_NNP ,_, the_DT membrane_NN was_VBD
          developed_VBN using_VBG ECL_NNP Western_NNP blotting_VBG system_NN and_CC Hyperfilm_NNP
          (_( Amersham_NNP Pharmacia_NNP Biotech_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) ._. The_DT
          antibody_NN used_VBN in_IN these_DT studies_NNS recognized_VBD bands_NNS of_IN the_DT
          expected_VBN size_NN for_IN pro-caspase-_JJ 8_CD (_( about_IN 55_CD kDa_NN )_) and_CC active_JJ
          caspase-_NN 8_CD (_( about_IN 20_CD kDa_NN )_) ._. In_IN other_JJ experiments_NNS ,_, samples_NNS
          containing_VBG 80_CD μg_NN total_JJ protein_NN underwent_VBD SDS-PAGE_NNP using_VBG
          15_CD %_NN polyacrylamide_NN gels_NNS ._. The_DT samples_NNS were_VBD transferred_VBN on_IN
          to_TO nitrocellulose_NN membranes_NNS ,_, which_WDT were_VBD incubated_JJ in_IN
          blocking_VBG buffer_NN (_( TBS_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, containing_VBG 10_CD %_NN dried_VBD milk_NN
          and_CC 0_CD ._. 1_CD %_NN Tween-_NNP 20_CD )_) and_CC then_RB rabbit_NN anti-_NN Bid_NNP antiserum_NN (_( BD_NNP
          PharMingen_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ,_, 1_CD :_: 2000_CD dilution_NN in_IN the_DT same_JJ
          blocking_VBG buffer_NN ,_, at_IN 4_CD °_NN C_NNP ,_, overnight_JJ ._. Following_VBG incubation_NN
          with_IN donkey_NN anti-rabbit_JJ IgG_NNP conjugated_JJ with_IN horseradish_NN
          peroxidase_NN (_( Santa_NNP Cruz_NNP Biotechnology_NNP Inc_NNP ._. Santa_NNP Cruz_NNP ,_,
          CA_NNP )_) ,_, 1_CD :_: 6000_CD dilution_NN ,_, for_IN 1_CD h_NN at_IN room_NN temperature_NN ,_, the_DT
          membrane_NN was_VBD developed_VBN as_IN described_VBN above_IN ._.
        
        
          Statistical_NNP analysis_NN
          All_DT data_NNS were_VBD presented_VBN as_IN mean_NN ±_NN standard_JJ error_NN ._.
          Significant_JJ differences_NNS were_VBD determined_VBN using_VBG one-way_JJ
          analysis_NN of_IN variance_NN with_IN standard_JJ post-hoc_JJ testing_NN
          (_( Statview_NNP ,_, version_NN 5_CD ._. 0_CD ,_, SAS_NNP Institute_NNP ,_, Cary_NNP ,_, NC_NNP )_) ._. A_DT P_NN
          value_NN of_IN <_NN 0_CD ._. 05_CD assigned_VBN statistical_JJ significance_NN ._.
        
      
      
        Results_NNS
        Kidneys_NNP of_IN S_NNP and_CC SD_NNP rats_NNS on_IN both_DT 0_CD ._. 3_CD %_NN and_CC 8_CD ._. 0_CD %_NN NaCl_NNP
        diets_NNS were_VBD examined_VBN on_IN days_NNS 7_CD and_CC 21_CD ._. The_DT blood_NN pressure_NN
        responses_NNS to_TO dietary_JJ salt_NN intake_NN of_IN the_DT Dahl_NNP /_NN Rapp_NNP S_NNP rat_NN ,_, an_DT
        experimental_JJ model_NN of_IN hypertensive_JJ nephrosclerosis_NNS ,_, and_CC of_IN
        the_DT SD_NNP strain_NN of_IN rat_NN have_VBP been_VBN published_VBN ._. After_IN seven_CD days_NNS
        on_IN the_DT high_JJ salt_NN diet_NN ,_, S_NNP rats_NNS were_VBD hypertensive_JJ (_( 146_CD ±_NN 2_CD mm_NN
        Hg_NNP )_) but_CC had_VBD preserved_VBN renal_JJ morphology_NN [_NN 5_CD ]_NN ._. By_IN day_NN 21_CD on_IN
        the_DT 8_CD ._. 0_CD %_NN NaCl_NNP diet_NN ,_, the_DT mean_JJ blood_NN pressure_NN increased_VBD to_TO
        169_CD ±_NN 7_CD mm_NN Hg_NNP [_NN 7_CD 27_CD 28_CD ]_NN ._. Mean_VB blood_NN pressures_NNS of_IN SD_NNP rats_NNS
        were_VBD not_RB influenced_VBN by_IN intake_NN of_IN salt_NN over_IN this_DT time_NN frame_NN
        of_IN study_NN (_( 118_CD ±_NN 4_CD mm_NN Hg_NNP on_IN the_DT 8_CD ._. 0_CD %_NN NaCl_NNP diet_NN ,_, compared_VBN to_TO
        115_CD ±_NN 4_CD mm_NN Hg_NNP on_IN the_DT 0_CD ._. 3_CD %_NN NaCl_NNP diet_NN )_) ._. In_IN addition_NN ,_, SD_NNP
        animals_NNS were_VBD healthy_JJ ,_, the_DT intake_NN of_IN either_DT diet_NN was_VBD
        similar_JJ ,_, and_CC they_PRP demonstrated_VBD no_DT renal_JJ abnormalities_NNS [_NN 27_CD
        28_CD 29_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, by_IN day_NN 21_CD the_DT kidneys_NNS of_IN S_NNP
        rats_NNS demonstrated_VBD significant_JJ vascular_NN ,_, glomerular_NN and_CC
        tubulo-interstitial_JJ injury_NN ._. TUNEL_NNP demonstrated_VBD apoptosis_NNS in_IN
        glomerular_NN and_CC tubular_JJ compartments_NNS (_( Fig_NNP 1_LS )_) ._. SD_NNP rats_NNS on_IN
        both_DT diets_NNS and_CC S_NNP rats_NNS on_IN 0_CD ._. 3_CD %_NN NaCl_NNP diet_NN demonstrated_VBN by_IN
        light_JJ microscopy_NN no_DT renal_JJ morphological_JJ alterations_NNS over_IN
        the_DT same_JJ period_NN of_IN study_NN ._. These_DT findings_NNS were_VBD similar_JJ to_TO
        previous_JJ publications_NNS from_IN this_DT laboratory_NN [_NN 5_CD 7_CD ]_NN ._.
        Using_VBG immunohistochemistry_NN ,_, expression_NN of_IN Fas_NNP was_VBD
        increased_VBN specifically_RB in_IN kidneys_NNS of_IN S_NNP rats_NNS on_IN 8_CD ._. 0_CD %_NN NaCl_NNP
        diet_NN by_IN day_NN 7_CD (_( Fig_NNP ._. 2_LS )_) ._. Staining_NNP was_VBD inhibited_VBD when_WRB the_DT
        anti-_NN Fas_NNP antibody_NN was_VBD pre-incubated_JJ with_IN recombinant_JJ
        soluble_JJ Fas_NNP (_( Fig_NNP ._. 2_LS Eand_NNP 2_CD J_NNP )_) ._. Quantification_NNP analysis_NN
        comparing_VBG the_DT four_CD groups_NNS of_IN rats_NNS in_IN the_DT study_NN showed_VBD that_DT
        expression_NN of_IN Fas_NNP in_IN glomerular_NN and_CC tubular_JJ cells_NNS was_VBD
        greatest_JJS (_( P_NN <_NN 0_CD ._. 05_CD )_) in_IN kidneys_NNS of_IN S_NNP rats_NNS exposed_VBN to_TO the_DT
        8_CD ._. 0_CD %_NN NaCl_NNP diet_NN for_IN 7_CD and_CC 21_CD days_NNS (_( Fig_NNP ._. 3_LS )_) ._. Comparing_VBG
        animals_NNS on_IN the_DT two_CD diets_NNS for_IN the_DT same_JJ duration_NN ,_, dietary_JJ
        salt_NN did_VBD not_RB alter_VB Fas_NNP expression_NN in_IN kidneys_NNS of_IN SD_NNP rats_NNS ._.
        The_DT increase_NN in_IN Fas_NNP expression_NN in_IN kidneys_NNS of_IN S_NNP rats_NNS on_IN the_DT
        8_CD ._. 0_CD %_NN NaCl_NNP diet_NN was_VBD observed_VBN in_IN cells_NNS in_IN the_DT glomeruli_NN ,_,
        tubules_NNS and_CC arteries_NNS (_( Fig_NNP ._. 4_LS A_DT ,_, B_NNP ,_, C_NNP )_) ._. Cytoplasmic_NNP staining_VBG
        was_VBD particularly_RB apparent_JJ in_IN these_DT samples_NNS ._.
        Over_IN the_DT same_JJ time_NN period_NN ,_, FasL_NNP expression_NN was_VBD also_RB
        examined_VBN (_( Fig_NNP ._. 5_LS A_DT ,_, B_NNP ,_, C_NNP ,_, D_NNP ,_, E_NNP ,_, F_NN ,_, G_NNP ,_, H_NNP ,_, I_PRP ,_, J_NNP )_) ._. The_DT anti-_NN FasL_NNP
        antibody_NN labeled_VBD cells_NNS in_IN both_DT glomerular_NN and_CC tubular_JJ
        compartments_NNS ,_, but_CC expression_NN was_VBD more_RBR subtle_JJ than_IN Fas_NNP ,_,
        particularly_RB in_IN the_DT glomeruli_NN ._. Quantification_NNP of_IN these_DT
        observations_NNS showed_VBD an_DT increase_NN in_IN expression_NN of_IN FasL_NNP in_IN
        both_DT glomerular_NN and_CC tubular_JJ compartments_NNS of_IN kidneys_NNS of_IN S_NNP
        rats_NNS on_IN the_DT 8_CD ._. 0_CD %_NN NaCl_NNP diet_NN ,_, compared_VBN with_IN the_DT other_JJ three_CD
        groups_NNS (_( Fig_NNP ._. 6_CD )_) ._. Again_RB ,_, dietary_JJ salt_NN did_VBD not_RB alter_VB
        glomerular_NN and_CC tubular_JJ expression_NN of_IN FasL_NNP in_IN kidneys_NNS of_IN SD_NNP
        rats_NNS ._. Tubular_NNP epithelial_NN cell_NN expression_NN of_IN FasL_NNP appeared_VBD
        to_TO be_VB predominantly_RB apical_JJ (_( Fig_NNP ._. 4_LS Dand_NNP 4_CD E_NNP )_) ,_, although_IN
        cytoplasmic_JJ staining_VBG was_VBD also_RB observed_VBN ,_, particularly_RB in_IN
        cells_NNS of_IN S_NNP rats_NNS on_IN the_DT 8_CD ._. 0_CD %_NN NaCl_NNP diet_NN ._. In_IN addition_NN ,_, some_DT
        tubular_JJ epithelial_NN cells_NNS of_IN kidneys_NNS from_IN S_NNP rats_NNS on_IN 8_CD ._. 0_CD %_NN
        NaCl_NNP diet_NN for_IN 21_CD days_NNS appeared_VBD to_TO express_VB both_DT Fas_NNP and_CC FasL_NNP
        (_( Fig_NNP ._. 4_LS F_NN ,_, Gand_NNP 4_CD H_NNP )_) ._.
        To_TO determine_VB whether_IN the_DT Fas_NNP /_NN FasL_NNP apoptotic_JJ pathway_NN was_VBD
        active_JJ ,_, Western_NNP blotting_VBG of_IN renal_JJ cortical_JJ lysates_NNS was_VBD
        performed_VBN using_VBG an_DT antibody_NN that_WDT recognized_VBD both_DT
        procaspase-_NN 8_CD and_CC the_DT active_JJ form_NN of_IN caspase-_NN 8_CD ._. In_IN these_DT
        experiments_NNS ,_, active_JJ caspase-_NN 8_CD was_VBD demonstrated_VBN in_IN lysates_NNS
        from_IN renal_JJ cortex_NN of_IN S_NNP rats_NNS on_IN 8_CD ._. 0_CD %_NN NaCl_NNP diet_NN for_IN three_CD
        weeks_NNS (_( Fig_NNP ._. 7_CD )_) ._. Active_JJ caspase-_NN 8_CD was_VBD not_RB demonstrated_VBN in_IN
        samples_NNS from_IN rats_NNS on_IN the_DT diet_NN for_IN 7_CD days_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        Tissue_NNP was_VBD also_RB examined_VBN for_IN cleavage_NN of_IN Bid_NNP ,_, which_WDT was_VBD
        identified_VBN specifically_RB in_IN lysates_NNS from_IN renal_JJ cortex_NN
        obtained_VBN from_IN S_NNP rats_NNS on_IN 8_CD ._. 0_CD %_NN NaCl_NNP diet_NN for_IN three_CD weeks_NNS
        (_( Fig_NNP ._. 7_CD )_) ._.
      
      
        Discussion_NNP
        Recent_JJ evidence_NN suggests_VBZ that_IN apoptosis_NNS is_VBZ involved_VBN in_IN
        several_JJ pathological_JJ processes_NNS in_IN the_DT lung_NN [_NN 30_CD 31_CD 32_CD ]_NN and_CC
        kidney_NN [_NN 33_CD 34_CD 35_CD 36_CD 37_CD ]_NN ._. Using_VBG the_DT Dahl_NNP /_NN Rapp_NNP
        salt-sensitive_JJ (_( S_NNP )_) rat_NN ,_, which_WDT develops_VBZ hypertensive_JJ
        nephrosclerosis_NNS that_WDT resembles_VBZ the_DT human_JJ disease_NN process_NN [_NN
        5_CD ]_NN ,_, this_DT laboratory_NN demonstrated_VBD an_DT early_JJ and_CC
        inappropriate_JJ apoptotic_JJ process_NN that_WDT occurred_VBD in_IN both_DT
        glomerular_NN and_CC tubular_JJ compartments_NNS of_IN the_DT kidneys_NNS and_CC
        correlated_JJ with_IN the_DT decline_NN in_IN glomerular_NN filtration_NN rate_NN ._.
        Apoptosis_NNP can_MD be_VB significant_JJ particularly_RB three_CD weeks_NNS into_IN
        the_DT course_NN of_IN hypertensive_JJ nephrosclerosis_NNS in_IN this_DT model_NN
        (_( Figure_NN 1_LS )_) ._. A_DT previous_JJ study_NN used_VBD RNase_NNP protection_NN assay_NN
        and_CC Western_NNP blotting_VBG to_TO demonstrate_VB an_DT increase_NN in_IN Fas_NNP
        expression_NN in_IN kidney_NN cortex_NN of_IN hypertensive_JJ S_NNP rats_NNS ._. These_DT
        findings_NNS were_VBD observed_VBN by_IN day_NN 21_CD of_IN study_NN [_NN 7_CD ]_NN ._. The_DT
        present_JJ series_NN of_IN experiments_NNS demonstrated_VBD the_DT diffuse_NN
        sites_NNS of_IN expression_NN of_IN Fas_NNP and_CC FasL_NNP in_IN the_DT kidney_NN and_CC
        explored_JJ further_VB the_DT possibility_NN that_IN the_DT Fas_NNP /_NN FasL_NNP pathway_NN
        was_VBD active_JJ during_IN the_DT development_NN of_IN hypertensive_JJ renal_JJ
        disease_NN in_IN this_DT rodent_NN model_NN of_IN hypertension_NN ._. Expression_NNP of_IN
        both_DT Fas_NNP and_CC FasL_NNP was_VBD observed_VBN in_IN kidneys_NNS of_IN both_DT SD_NNP and_CC S_NNP
        rats_NNS ,_, but_CC specifically_RB increased_VBN over_IN time_NN in_IN hypertensive_JJ
        S_NNP rats_NNS ._. Associated_NNP with_IN the_DT increased_VBN expression_NN was_VBD
        cleavage_NN of_IN procaspase-_NN 8_CD to_TO produce_VB the_DT active_JJ enzyme_NN and_CC
        cleavage_NN of_IN Bid_NNP ,_, indicating_VBG activation_NN of_IN the_DT Fas_NNP /_NN FasL_NNP
        apoptotic_JJ pathway_NN in_IN the_DT course_NN of_IN progressive_JJ renal_JJ
        failure_NN ._. These_DT data_NNS ,_, along_IN with_IN the_DT previous_JJ studies_NNS that_WDT
        confirmed_VBD morphological_JJ evidence_NN of_IN apoptosis_NNS and_CC
        biochemical_JJ evidence_NN of_IN caspase-_NN 3_CD activation_NN in_IN these_DT
        kidneys_NNS [_NN 7_CD ]_NN ,_, showed_VBD a_DT role_NN for_IN the_DT Fas_NNP /_NN FasL_NNP pathway_NN in_IN
        promoting_VBG the_DT loss_NN of_IN kidney_NN function_NN that_WDT develops_VBZ in_IN the_DT
        setting_NN of_IN hypertensive_JJ nephrosclerosis_NNS in_IN this_DT model_NN ._.
        The_DT mechanism_NN of_IN augmented_JJ Fas_NNP and_CC FasL_NNP expression_NN in_IN
        kidneys_NNS of_IN hypertensive_JJ S_NNP rats_NNS is_VBZ uncertain_JJ ._. In_IN addition_NN to_TO
        apoptotic_JJ signaling_VBG ,_, the_DT Fas_NNP /_NN FasL_NNP system_NN may_MD also_RB be_VB
        involved_VBN in_IN proliferation_NN ._. Hueber_NNP ,_, et_CC al_NN ._. ,_, showed_VBD that_IN Fas_NNP
        might_MD promote_VB T-_NNP cell_NN proliferation_NN by_IN modulating_VBG release_NN of_IN
        calcium_NN from_IN intracellular_NN stores_NNS [_NN 38_CD ]_NN ._. FasL_NNP is_VBZ
        anti-proliferative_JJ by_IN regulating_VBG cell-cycle_JJ progression_NN [_NN
        39_CD ]_NN ._. Previous_JJ studies_NNS demonstrated_VBD an_DT increase_NN in_IN cell_NN
        proliferation_NN rates_NNS in_IN kidneys_NNS of_IN S_NNP rats_NNS on_IN the_DT high-salt_JJ
        diet_NN [_NN 7_CD ]_NN ,_, so_IN it_PRP is_VBZ possible_JJ that_IN Fas_NNP and_CC FasL_NNP may_MD play_VB a_DT
        role_NN in_IN control_NN of_IN proliferation_NN ._. Another_DT potential_JJ
        explanation_NN is_VBZ tissue_NN hypoxia_NN ,_, which_WDT has_VBZ been_VBN suggested_VBN to_TO
        upregulate_NN Fas_NNP in_IN the_DT kidney_NN [_NN 36_CD 37_CD ]_NN ._. MDCK_NNP cells_NNS in_IN
        culture_NN demonstrated_VBN increased_VBN expression_NN of_IN Fas_NNP ,_, FasL_NNP and_CC
        FADD_NNP in_IN response_NN to_TO partial_JJ ATP_NNP depletion_NN [_NN 40_CD ]_NN ._. Fas_NNP and_CC
        FasL_NNP expression_NN in_IN the_DT kidney_NN may_MD serve_VB as_IN indicators_NNS of_IN
        cellular_JJ stress_NN ._. Tissue_NNP hypoxia_NN therefore_RB remains_VBZ a_DT
        possible_JJ mechanism_NN of_IN increased_VBN expression_NN of_IN Fas_NNP and_CC FasL_NNP ,_,
        although_IN it_PRP seems_VBZ less_RBR likely_JJ that_IN the_DT arteriolosclerosis_NNS
        that_WDT developed_VBD in_IN S_NNP kidneys_NNS was_VBD severe_JJ enough_RB to_TO produce_VB
        hypoxic_JJ conditions_NNS sufficient_JJ to_TO up-regulate_JJ Fas_NNP ,_, until_IN the_DT
        third_JJ week_NN of_IN study_NN ._.
        Increased_VBN expression_NN of_IN Fas_NNP and_CC FasL_NNP appeared_VBD to_TO
        increase_VB the_DT propensity_NN to_TO undergo_VB apoptosis_NNS ,_, but_CC was_VBD not_RB
        the_DT sole_JJ determinant_NN of_IN this_DT process_NN ._. Despite_IN the_DT increase_NN
        in_IN expression_NN of_IN Fas_NNP and_CC FasL_NNP at_IN day_NN 7_CD of_IN study_NN ,_, caspase-_NN 8_CD
        activation_NN and_CC Bid_NNP cleavage_NN were_VBD not_RB observed_VBN ._.
        Fas_NNP /_NN FasL-mediated_NNP apoptotic_JJ signaling_VBG is_VBZ modulated_JJ by_IN other_JJ
        intracellular_NN factors_NNS ._. Induction_NNP of_IN inhibitor_NN of_IN apoptosis_NNS
        proteins_NNS (_( IAP_NNP )_) is_VBZ one_CD such_JJ mechanism_NN [_NN 41_CD 42_CD 43_CD ]_NN ._. In_IN
        vascular_NN smooth_JJ muscle_NN cells_NNS ,_, surface_NN expression_NN of_IN Fas_NNP [_NN
        44_CD ]_NN and_CC molecules_NNS involved_VBN in_IN signaling_VBG the_DT apoptotic_JJ
        process_NN ,_, such_JJ as_IN caspase-_NN 8_CD and_CC caspase-_NN 3_CD ,_, appear_VBP to_TO be_VB
        regulated_VBN and_CC provide_VB another_DT level_NN of_IN cellular_JJ control_NN of_IN
        apoptosis_NNS [_NN 45_CD ]_NN ._. However_RB ,_, the_DT potential_JJ anti-apoptotic_JJ
        mechanisms_NNS present_JJ early_RB in_IN the_DT course_NN were_VBD ineffective_JJ by_IN
        day_NN 21_CD ,_, when_WRB caspase-_NN 8_CD activation_NN was_VBD evident_JJ ._. A_DT previous_JJ
        study_NN suggested_VBD that_IN the_DT apoptotic_JJ process_NN occurred_VBD early_RB
        in_IN the_DT development_NN of_IN hypertension_NN in_IN this_DT model_NN [_NN 26_CD ]_NN ,_,
        so_IN the_DT data_NNS suggested_VBD that_IN an_DT apoptotic_JJ mechanism_NN in_IN
        addition_NN to_TO activation_NN of_IN the_DT Fas_NNP /_NN FasL_NNP pathway_NN is_VBZ also_RB
        involved_VBN in_IN development_NN of_IN hypertensive_JJ nephrosclerosis_NNS in_IN
        S_NNP rats_NNS ._.
        In_IN conclusion_NN ,_, kidneys_NNS of_IN S_NNP rats_NNS have_VBP been_VBN shown_VBN to_TO be_VB
        very_RB sensitive_JJ to_TO hypertensive_JJ injury_NN ,_, which_WDT is_VBZ mediated_JJ at_IN
        least_JJS in_IN part_NN by_IN the_DT apoptotic_JJ mechanism_NN controlled_VBN by_IN Fas_NNP ._.
        Augmented_NNP expression_NN of_IN both_DT Fas_NNP and_CC FasL_NNP by_IN glomerular_NN and_CC
        tubular_JJ cells_NNS resulted_VBD in_IN caspase-_NN 8_CD activation_NN ._. The_DT
        pronounced_VBN increases_NNS in_IN Fas_NNP and_CC FasL_NNP expression_NN and_CC
        activation_NN of_IN this_DT pathway_NN by_IN the_DT third_JJ week_NN of_IN study_NN also_RB
        correlated_JJ with_IN previous_JJ evidence_NN that_WDT documented_VBN
        irreversibility_NN of_IN the_DT renal_JJ injury_NN if_IN the_DT hypertension_NN was_VBD
        not_RB corrected_VBN by_IN this_DT time_NN [_NN 5_CD ]_NN ._. These_DT data_NNS supported_VBD the_DT
        view_NN that_IN the_DT Fas_NNP /_NN FasL_NNP pathway_NN promoted_VBD nephrosclerosis_NNS in_IN
        this_DT model_NN ._. Activation_NNP of_IN the_DT Fas_NNP /_NN FasL_NNP pathway_NN may_MD also_RB
        serve_VB as_IN a_DT mechanism_NN of_IN tubular_JJ epithelial_NN cell_NN loss_NN and_CC
        interstitial_NN fibrosis_NNS ,_, which_WDT are_VBP also_RB prominent_JJ renal_JJ
        features_NNS of_IN hypertension_NN ._. The_DT role_NN of_IN the_DT Fas_NNP /_NN FasL_NNP pathway_NN
        in_IN human_JJ hypertensive_JJ nephrosclerosis_NNS remains_VBZ to_TO be_VB
        determined_VBN ._.
      
      
        Abbreviations_NNP
        SD_NNP ,_, Sprague-_NNP Dawley_NNP rat_NN
        S_NNP ,_, Dahl_NNP /_NN Rapp_NNP salt-sensitive_JJ rat_NN
        Fas_NNP ,_, Fas_NNP antigen_NN (_( or_CC CD_NNP 95_CD and_CC APO-_NNP 1_LS )_)
        FasL_NNP ,_, Fas_NNP antigen_NN ligand_NN (_( or_CC CD_NNP 95_CD L_NNP and_CC APO-_NNP 1_CD L_NNP )_)
        PBS_NNP ,_, phosphate-buffered_JJ saline_NN
        RIPA_NNP ,_, radioimmunoprecipitation_NN assay_NN
        SDS_NNP ,_, sodium_NN dodecyl_NN sulfate_NN
        TBS_NNP ,_, Tris-buffered_NNP saline_NN
        Bid_NNP ,_, Bcl-_NNP 2_CD -_: interactive-death-agonist_JJ ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
      
    
  
